Cwestiwn ysgrifenedig WQ96354
- Gofynnwyd gan
- Mabon ap GwynforPlaid
- I'w ateb gan
- Cabinet Secretary for Health and Social Care
- Cyflwynwyd
- Dyddiad ateb
- Atebwyd
- Amser i'w ateb
- 6 diwrnod
Cwestiwn
Mae'r cwestiwn a'r ateb yn Saesneg gan nad oes fersiwn Gymraeg ar gael.
What consideration has the Cabinet Secretary given to the Global Initiative for Chronic Obstructive Lung Disease 2025 annual report on Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease?
Ateb
Atebwyd gan Cabinet Secretary for Health and Social Care
The Welsh Government’s approach to improving clinical services for conditions such as COPD was set out in the National Clinical Framework and resulted in the introduction of the Quality Statement for Respiratory Disease:
Quality statement for respiratory disease | GOV.WALES
This sets out the Welsh Government’s expectations for the NHS in Wales regarding planning services for people affected by non-communicable respiratory conditions, including COPD.
As a result, the Welsh Government expects the NHS in Wales to apply clinical standards and guidelines on the diagnosis and management of COPD issued by the All-Wales Medicines Strategy Group (AWMSG) and the National Institute for Health and Care Excellence (NICE). AWMSG and NICE take an evidence-based approach to guidelines and technology appraisals. Stakeholders can inform the development of these guidelines by contact these organisations. More information can be found at:
Introduction | Tools and resources | Developing NICE guidelines: the manual | Guidance | NICE
Contact us - All Wales Therapeutics and Toxicology Centre